Search This Blog

Tuesday, February 25, 2025

Harmony Biosciences Holdings, Inc Q4 Profit Increases, Beats Estimates

 Harmony Biosciences Holdings, Inc (HRMY) released earnings for its fourth quarter that increased from the same period last year and beat the Street estimates.

The company's bottom line totaled $49.48 million, or $0.85 per share. This compares with $26.61 million, or $0.45 per share, last year.

Excluding items, Harmony Biosciences Holdings, Inc reported adjusted earnings of $63.03 million or $1.08 per share for the period.

Analysts on average had expected the company to earn $0.82 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period rose 19.5% to $201.27 million from $168.41 million last year.

Harmony Biosciences Holdings, Inc earnings at a glance (GAAP) :

-Earnings: $49.48 Mln. vs. $26.61 Mln. last year. -EPS: $0.85 vs. $0.45 last year. -Revenue: $201.27 Mln vs. $168.41 Mln last year.


https://www.nasdaq.com/articles/harmony-biosciences-holdings-inc-q4-profit-increases-beats-estimates

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.